Active substances: Ciprofloxacin
Conclusions The dosing of paclitaxel-carboplatin was appropriate, following the ASCO recommendations including for overweight and obese patients.
Having the limitation of the small sample size, we recorded less neutropenia in the obese group. Purpose To evaluate the efficacy and safety of bevacizumab as an antiangiogenic drug in the treatment of macular oedema secondary to RVO.
For each patient, the following data were collected: age and gender, type of occlusion and adverse reactions detected.
The variable used to evaluate the efficacy of the treatment was the improvement in the visual acuity, measured by the Snellen fraction adapted to decimal between 0.
Results 18 patients with macular oedema secondary to RVO were treated, with a total of 46 doses, and an average of 2. In all cases we used intravitreal bevacizumab as the antiangiogenic drug.
No loss of visual acuity has been recorded in any patients. No adverse reactions have been reported.
Conclusions In our group of patients, intravitreal bevacizumab was an effective and safe treatment of macular oedema secondary to RVO. The efficacy data obtained are consistent with the reported bibliography.
Despite proven efficacy of antidepressant medicines, the effectiveness of antidepressants is reduced by patient non-adherence. Several factors can contribute to antidepressant non adherence.
There is evidence to support the hypothesis that patient satisfaction will result in improved adherence and improved clinical outcomes.
Purpose To assess the relationship between medicines adherence and treatment satisfaction with antidepressants in depressed patients.Associations between echocardiographic manifestations and bacterial selected from positive blood culture and for patients with negative blood culture, bacteria found in culture or PCR from postoperative material was registered. Methods In this cohort study, data species in patients with infective endocarditis: a cohort study Latest Results for BMC Infectious Diseases, 16.
Results A sample of 200 patients using antidepressants was studied. Based on MMAS-8, 37. Severity of depression was correlated with adherence score.
However, variables like use of monotherapy or age and sex were not significantly associated with higher adherence.
The satisfaction means with regard to effectiveness, side effects, convenience and global satisfaction were low scores. Conclusions Non adherence to antidepressants was common and was associated with low treatment satisfaction scores and increased severity of depression symptom scores.
The black triangle will be used in all EU Member States to identify medicines subject to additional monitoring, such as belimumab.